Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockBearish
4
Neutral
6
Bullish
4
Bearish
22
Neutral
6
Bullish
18
Bearish
18
Neutral
0
Bullish
14
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Chemfab Alkalis Limited manufactures caustic soda and related chlor‑alkali products from a 65,700 TPA plant and has a high‑growth OPVC pipes business producing up to 630mm diameter pipes, with manufacturing units in Puducherry and Sri City and a ~59:41 revenue mix favouring chlor‑alkali in FY25.
The company is actively modernising its chlor‑alkali operations with a ₹60 crore technology upgrade completed in December 2025 and a ₹15 crore hybrid power investment expected to deliver significant annual cost savings once ISTS transmission clearances enable power supply from Q4FY26.
Chemfab has rapidly scaled OPVC production through a plug‑and‑play model with Molecor technology, expanding from 3,000 TPA in 2018 to a planned 23,000 TPA in FY26; each new line has an estimated ₹45–50 crore revenue potential and a 2–2.5 year payback period.
Recent quarter results show a trough in consolidated performance with Q3FY26 consolidated revenue of ₹62.17 crore and operational EBITDA of ₹5.17 crore; OPVC margins compressed sequentially due to slow Jal Jeevan Mission fund flows, while chlor‑alkali ECU realisations show signs of stabilising around ₹38,500/MT.
Chemicals & Petrochemicals
Commodity Chemicals
531 Cr
Moderate Risk
0.0
44.1
—
1.4
845.65
270.00
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q4 FY26
Investor Presentation
Q3 FY26
Investor Presentation
Q2 FY26
Investor Presentation
Q1 FY26
Discovery themes featuring this stockChemfab Alkalis Ltd (CHEMFAB) is currently trading at 369.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Chemfab Alkalis Limited manufactures caustic soda and related chlor‑alkali products from a 65,700 TPA plant and has a high‑growth OPVC pipes business producing up to 630mm diameter pipes, with manufacturing units in Puducherry and Sri City and a ~59:41 revenue mix favouring chlor‑alkali in FY25. The company is actively modernising its chlor‑alkali operations with a ₹60 crore technology upgrade completed in December 2025 and a ₹15 crore hybrid power investment expected to deliver significant annual cost savings once ISTS transmission clearances enable power supply from Q4FY26. Chemfab has rapidly scaled OPVC production through a plug‑and‑play model with Molecor technology, expanding from 3,000 TPA in 2018 to a planned 23,000 TPA in FY26; each new line has an estimated ₹45–50 crore revenue potential and a 2–2.5 year payback period. Recent quarter results show a trough in consolidated performance with Q3FY26 consolidated revenue of ₹62.17 crore and operational EBITDA of ₹5.17 crore; OPVC margins compressed sequentially due to slow Jal Jeevan Mission fund flows, while chlor‑alkali ECU realisations show signs of stabilising around ₹38,500/MT.
Over the past 52 weeks, Chemfab Alkalis Ltd has traded between a low of ₹270.00 and a high of ₹845.65. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Chemfab Alkalis Ltd has a market capitalization of approximately 531.11. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Chemfab Alkalis Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of N/A and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 531.11 Cr, Chemfab Alkalis Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Chemfab Alkalis Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Chemfab Alkalis Ltd is N/A. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
1079.00 | 590 Cr | 12.92 | 0.77 | 1.89 | 5.95 | 8.23 | 4.53 | ||
9.01 | 543 Cr | 450.50 | 8.83 | 0.00 | 1.68 | 2.22 | 1.25 | ||
22.07 | 535 Cr | 34.48 | 1.44 | 0.00 | 3.78 | 6.57 | 1.52 | ||
369.50 | 531 Cr | — | 1.41 | 0.34 | -0.91 | 1.49 | -0.59 | ||
172.30 | 530 Cr | 12.73 | 2.72 | 0.46 | 21.32 | 21.36 | 10.86 | ||
530.00 | 454 Cr | 15.94 | 1.42 | 0.00 | 8.94 | 9.59 | 3.48 | ||
149.00 | 426 Cr | 14.95 | 1.76 | 0.00 | 11.75 | 11.51 | 5.95 | ||
| Median: 7 Co. | — | 172.30 | 531 Cr | 15.45 | 1.44 | 0.00 | 5.95 | 8.23 | 3.48 |
Board Meeting
Chemfab Alkalis Ltd: Board meeting scheduled on 2026-07-29 at 12:00 to consider and approve unaudited standalone and consolidated results for quarter ended 30-06-2026. Trading window closed from 2026-07-01 to 2026-07-31.
Board Meeting
Chemfab Alkalis scheduled a Board meeting on 29-07-2026 at 12:00 PM to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30-06-2026; trading window closed from 01-07-2026 to 31-07-2026.
